全球腸外營養市場 - 市場規模、佔有率、成長分析：按消費者、最終用戶分類 - 產業預測（2023-2030）

Global Parenteral Nutrition Market Size, Share, Growth Analysis, By Consumer(Children and Newborns, and Adults), By End user(Clinics, Hospitals) - Industry Forecast 2023-2030

出版日期: 2023年10月13日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計2021年全球腸外營養市場規模為63.3億美元，2022年為67.1億美元。預計該市場在預測期（2023年至2030年）將以6.0%的年複合成長率擴張，到2030年將成長至107億美元。

全球腸外營養市場在過去年度中經歷了顯著成長，預計未來將繼續擴大。推動全球腸外營養市場成長的主要因素之一是慢性病和胃腸道疾病的盛行率不斷增加。癌症、克隆氏症和短腸症候群等疾病需要使用腸外營養來確保足夠的營養並支持患者康復。此外，容易出現營養不良和相關併發症的老年人口的增加也促進了市場的成長。推動市場擴張的另一個因素是腸外營養配方和技術的進步。製造商專注於開發創新產品，以改善患者治療效果、減少併發症並提高給藥便利性。例如，具有可客製化營養組合的多室袋的推出簡化了腸外營養溶液的製備過程，使醫療保健專業人員和患者受益。然而，全球腸外營養市場也面臨一些挑戰。一個重要的障礙是與長期腸外營養治療相關的感染疾病和併發症的風險。導管相關的血流感染和代謝併發症對患者構成重大風險，需要嚴格的感染控制措施和仔細監測。此外，腸外營養解決方案和相關設備的高成本可能會限制市場成長，特別是在醫療保健預算有限的新興市場。

創新配方、改良營養組合和先進輸送系統的開發正在提高腸外營養治療的安全性和有效性。這些進步使腸外營養給藥對醫療保健提供者來說更加方便，並且患者的耐受性更好。

人們越來越認知到營養在整體健康和疾病管理中的重要性。人們對營養在患者預後中的作用的認知不斷加深，導致對腸外營養治療作為綜合醫療保健一部分的需求增加。

有關腸外營養治療的法規因地區而異，指南也不標準化，這給製造商和醫療保健提供者帶來了挑戰。協調法律規範和製定循證指南對於確保安全有效地給藥腸外營養至關重要。

長期依賴腸外營養可出現肝功能障礙、體液失衡及電解質異常等併發症。必須仔細管理這些限制和併發症，以確保腸外營養的最佳使用並最大限度地降低患者的風險。

該報告研究了全球腸外營養市場，並提供了市場概述，包括消費者、最終用戶、地區的趨勢以及參與市場的公司概況。

主要企業簡介
- Fresenius Kabi
- B. Braun Melsungen AG
- Baxter International Inc.
- Grifols SA
- Otsuka Pharmaceutical Co., Ltd.
- Pfizer Inc.
- Aculife Healthcare Pvt. Ltd.
- Vifor Pharma
- Sichuan Kelun Pharmaceutical Co., Ltd.
- ALLERGAN
- Claris Lifesciences Limited
- Actavis plc
- ABBOTT
- AstraZeneca
- Medtronic
- Beximco Pharmaceuticals Ltd.
- Sichuan Luye Pharmaceutical Co., Ltd.
- ICU Medical, Inc.
- JW Pharmaceutical Corporation
- Hospira, Inc.

簡介目錄

Product Code: SQMIG35C2016

Global Parenteral Nutrition Market size was valued at USD 6.33 Billion in 2021 and is poised to grow from USD 6.71 Billion in 2022 to USD 10.7 Billion by 2030, at a CAGR of 6.0% during the forecast period (2023-2030).

The global parenteral nutrition market has experienced significant growth over the past years and is expected to continue expanding in the coming years. One of the key drivers fueling the growth of the global parenteral nutrition market is the increasing prevalence of chronic diseases and gastrointestinal disorders. Conditions such as cancer, Crohn's disease, and short bowel syndrome necessitate the use of parenteral nutrition to ensure adequate nutrition and support patient recovery. Moreover, the rising geriatric population, who are more prone to malnutrition and related complications, has contributed to the market growth. Another factor driving market expansion is the advancements in parenteral nutrition formulations and technologies. Manufacturers are focusing on developing innovative products that improve patient outcomes, reduce complications, and enhance the ease of administration. For instance, the introduction of multi-chamber bags that allow for customized nutrient combinations has simplified the process of preparing parenteral nutrition solutions, benefiting both healthcare professionals and patients. However, the global parenteral nutrition market also faces several challenges. One of the significant hurdles is the risk of infections and complications associated with long-term parenteral nutrition therapy. Catheter-related bloodstream infections and metabolic complications pose substantial risks to patients, requiring stringent infection control measures and careful monitoring. Furthermore, the high cost of parenteral nutrition solutions and associated equipment can limit market growth, especially in developing regions with limited healthcare budgets.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Parenteral Nutrition Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Parenteral Nutrition Market Segmental Analysis

The global parenteral nutrition market is segmented on the basis of consumer, end user, and region. By consumer, the market is segmented into Children and Newborns, and Adults. By end user, the market is segmented into Clinics, Hospitals, and Others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Parenteral Nutrition Market Dynamics

Drivers of the Global Parenteral Nutrition Market

Technological Advancements in Parenteral Nutrition Products

The development of innovative formulations, improved nutrient combinations, and advanced delivery systems has enhanced the safety and efficacy of parenteral nutrition therapy. These advancements have made parenteral nutrition administration more convenient for healthcare providers and more tolerable for patients.

Increasing Awareness about Clinical Nutrition

There is a growing awareness of the importance of nutrition in overall health and disease management. This increased understanding of the role of nutrition in patient outcomes has led to a higher demand for parenteral nutrition therapy as a part of comprehensive healthcare.

Restraints in the Global Parenteral Nutrition Market

Regulatory Constraints and Lack of Standardization

Variations in regulations and lack of standardized guidelines for parenteral nutrition therapy across different regions pose challenges for manufacturers and healthcare providers. Harmonization of regulatory frameworks and the development of evidence-based guidelines are essential for ensuring safe and effective administration of parenteral nutrition.

Potential Complications and Limitations of Long-term Use

Prolonged dependence on parenteral nutrition may present complications such as liver dysfunction, fluid imbalances, and electrolyte abnormalities. These limitations and complications need to be carefully managed to ensure the optimal use of parenteral nutrition and minimize risks to patients.

Market Trends of Global Parenteral Nutrition Key

Integration of Digital Health Technologies: Digital health technologies, such as mobile applications, connected devices, and telehealth solutions, are being integrated into parenteral nutrition therapy. These technologies enable remote monitoring, real-time data collection, and improved communication between patients, caregivers, and healthcare providers, leading to better patient management and enhanced treatment outcomes.

Focus on Quality Control and Product Safety: With the increasing importance of patient safety, there is a growing focus on quality control and product safety in the manufacturing and administration of parenteral nutrition solutions. Companies are implementing stringent quality assurance processes, adhering to regulatory guidelines, and investing in technologies to ensure the safety and efficacy of their products.

Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
- Regulatory Landscape
- Porters Analysis
Competitive rivalry
Threat of Substitute Products
Bargaining Power of Buyers
Threat of New Entrants
Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
Political Impact
Economic Impact
Social Impact
Technical Impact
Environmental Impact
Legal Impact
Global Parenteral Nutrition Market by Consumer
- Market Overview
- Children and Newborns
- and Adults
Global Parenteral Nutrition Market by End user
- Market Overview
- Clinics
- Hospitals
- and Others
Global Parenteral Nutrition Market Size by Region
- Market Overview
- North America
USA
Canada
- Europe
Germany
Spain
France
UK
Rest of Europe
- Asia Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
- Latin America
Brazil
Rest of Latin America
- Middle East & Africa (MEA)
GCC Countries
South Africa
Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
By Development
By Company
By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Fresenius Kabi (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- B. Braun Melsungen AG (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Baxter International Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Grifols SA (Spain)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Otsuka Pharmaceutical Co., Ltd. (Japan)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Pfizer Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Aculife Healthcare Pvt. Ltd. (India)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Vifor Pharma (Switzerland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Sichuan Kelun Pharmaceutical Co., Ltd. (China)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- ALLERGAN (Ireland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Claris Lifesciences Limited (India)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Actavis plc (Ireland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- ABBOTT (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- AstraZeneca (UK)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Medtronic (Ireland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Beximco Pharmaceuticals Ltd. (Bangladesh)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Sichuan Luye Pharmaceutical Co., Ltd. (China)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- ICU Medical, Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- JW Pharmaceutical Corporation (South Korea)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Hospira, Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments